Journal article
O-311 A phase III study of Æ-941 (Neovastat®) with induction chemotherapy (IC) and conconmitant chemoradiotherapy (CRT) for stage III non-small cell lung cancer (NSCLC) (NCI T99-0046, RTOG 02-70, MDA 99-303): An interim analysis of toxicity and response
Authors
Lu C; Komaki R; Herbst RS; Evans WK; Smith TL; Moore CA; Kolbye SL; Choi NC; Choy H; Bleyer A
Journal
Lung Cancer, Vol. 41, ,
Publisher
Elsevier
Publication Date
August 1, 2003
DOI
10.1016/s0169-5002(03)91969-6
ISSN
0169-5002